G NKontchou
Overview
Explore the profile of G NKontchou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doreille A, NKontchou G, Halimi A, Bouhafs F, Coderc E, Sellier N, et al.
Diagn Interv Imaging
. 2016 May;
97(11):1117-1123.
PMID: 27138073
Purpose: The goal of this study was to retrospectively evaluate the results of imaging-guided percutaneous ablation in patients with controlled intrahepatic hepatocellular carcinoma (HCC) with limited extrahepatic disease. Materials And...
2.
Lahbabi M, NKontchou G, Aout M, Vicaud E, Ganne N, Trinchet J, et al.
Rev Med Interne
. 2012 Jan;
33(3):128-33.
PMID: 22226387
Purpose: The objective of this study was to assess the results and tolerance of radiofrequency ablation in patients with cirrhosis and hepatocellular carcinoma (HCC) older than 75 years. Patients And...
3.
NKontchou G, Ziol M, Aout M, Lhabadie M, Baazia Y, Mahmoudi A, et al.
J Viral Hepat
. 2011 Sep;
18(10):e516-22.
PMID: 21914071
Liver steatosis is a main histopathological feature of Hepatitis C (HCV) infection because of genotype 3. Steatosis and/or mechanisms underlying steatogenesis can contribute to hepatocarcinogenesis. The aim of this retrospective...
4.
Seror O, NKontchou G, Muhammad M, Barrucand C, Tin Tin Htar M, Assaban M, et al.
J Radiol
. 2007 Sep;
88(9 Pt 1):1157-64.
PMID: 17878877
Purpose: To evaluate the risk of radiofrequency ablation treatment failure for hepatocellular carcinomas (HCC) next to large vessels. Materials And Methods: Between May 2000 and October 2002, from a total...
5.
Vallet S, Gouriou S, NKontchou G, Hotta H, Vilerio M, Legrand-Quillien M, et al.
J Viral Hepat
. 2007 Jan;
14(2):96-106.
PMID: 17244249
We investigated whether an HCV NS3 protease quasispecies heterogeneity was associated with progression from viral cirrhosis to hepatocellular carcinoma (HCC). The NS3 protease quasispecies structure of 10 HCV-1b cirrhotic patients...
6.
Ward D, Cheng Y, NKontchou G, Thar T, Barget N, Wei W, et al.
Br J Cancer
. 2006 Oct;
95(10):1379-83.
PMID: 17060939
SELDI-based proteomic profiling of body fluids is currently in widespread use for cancer biomarker discovery. We have successfully used this technology for the diagnosis of hepatocellular carcinoma (HCC) in hepatitis...
7.
Ward D, Cheng Y, NKontchou G, Thar T, Barget N, Wei W, et al.
Br J Cancer
. 2006 Jan;
94(2):287-92.
PMID: 16404431
Early diagnosis of hepatocellular carcinoma (HCC) is the key to the delivery of effective therapies. The conventional serological diagnostic test, estimation of serum alpha-fetoprotein (AFP) lacks both sensitivity and specificity...
8.
NKontchou G, Cosnes J, Carbonnel F, Beaugerie L, Ngo Y, Malafosse M, et al.
Gastroenterol Clin Biol
. 1996 Mar;
20(2):166-71.
PMID: 8761676
Objective: To assess the prognosis of pancolitis in ulcerative colitis including survival, colectomy rate, colon cancer risk, activity of disease, functional and socioprofessional impact. Methods: Retrospective study of 130 cases...
9.
NKontchou G, Gaudouen Y, Rouaud J, Pacault J, Amouroux J, CAROIT M
Rev Rhum Mal Osteoartic
. 1992 Jan;
59(1):81-2.
PMID: 1579851
No abstract available.